Smith J F, Baker J M
Department of Obstetrics and Gynecology, United States Naval Hospital, Portsmouth, Virginia, USA.
Obstet Gynecol. 1994 Oct;84(4 Pt 2):670-2.
Crigler-Najjar disease, a rare cause of maternal unconjugated hyperbilirubinemia in pregnancy, poses no threat to the mother, and the elevated bilirubin levels do not seem harmful to the fetus. However, the disease is expressed in two forms, one of which is fatal.
The maternal total bilirubin (mostly unconjugated) was 8.5 mg/dL in the first trimester, fell to 5.0 mg/dL in the second, and rose again to 8.8 mg/dL at term. The infant was jaundiced at birth, with umbilical cord total bilirubin at 7.6 mg/dL. The jaundice resolved without treatment, and no sequelae of hyperbilirubinemia were present.
Crigler-Najjar disease type II seems to pose no unique maternal risk during pregnancy. The fetus seems to be resistant to elevated maternal unconjugated bilirubin, but the neonate may required therapy for hyperbilirubinemia.
克里格勒 - 纳贾尔病是孕期母体非结合胆红素血症的罕见病因,对母亲无威胁,且胆红素水平升高似乎对胎儿无害。然而,该疾病有两种表现形式,其中一种是致命的。
孕早期母体总胆红素(主要是非结合胆红素)为8.5mg/dL,孕中期降至5.0mg/dL,足月时又升至8.8mg/dL。婴儿出生时黄疸,脐带血总胆红素为7.6mg/dL。黄疸未经治疗自行消退,且无高胆红素血症后遗症。
II型克里格勒 - 纳贾尔病在孕期似乎不会给母亲带来独特风险。胎儿似乎对母体非结合胆红素升高具有抵抗力,但新生儿可能需要接受高胆红素血症治疗。